Brief: Arterra Bioscience Subscribes To ADL Farmaceutici's Cash Call For EUR 360,000
25/06/2021 16:56
June 25 (Reuters) - Arterra Bioscience SpA ABIS.MI :
* SUBSCRIBES TO CASH CALL OF ADL FARMACEUTICI FOR EUR 360,000
* SIGNS RESEARCH AND DEVELOPMENT DEAL WITH ADL FARMACEUTICI FOR EUR 35,000 /YEAR IN FAVOUR
OF
ARTERRA
Further company coverage: ABIS.MI
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Arterra Bioscience SpA
See all newsBrief: Arterra Bioscience - Q1 Revenue EUR 1.6 Million
Brief: Arterra Bioscience Re-Food Project Approved For Financing, Granted Non-Repayable Contribution Of Around EUR 0.5 Mln
Brief: Arterra Bioscience FY Net Profit EUR 2.0 Mln
Brief: Arterra Bioscience FY Revenue At EUR 4.6 Mln
Brief: Arterra Bioscience Shareholder Maria Gabriella Colucci Sells 466,500 Shares At EUR 3.20/SHR To Smart Capital